# Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma

> **NCT00006021** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 22 (actual)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DIETARY_SUPPLEMENT:** ascorbic acid
- **DRUG:** arsenic trioxide

## Key facts

- **NCT ID:** NCT00006021
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2006-05
- **Final completion:** 2007-03
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2016-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006021, "Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00006021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*